Prompt arousal from fentanyl-droperidol-pentobarbital anesthesia in dogs: a preliminary study.
Groups of fentanyl-droperidol-pentobarbital-anesthetized dogs (n = 6 dogs/group) were given IV saline solution (control group), graded doses of naloxone (0.01, 0.1, 1.0, 10.0 mg/kg) or fixed doses of 4-aminopyridine (0.5 mg/kg), yohimbine (0.4 mg/kg), or doxapram (5.0 mg/kg) alone or in combination with a fixed dose of naloxone (1.0 mg/kg). The purpose was to determine which drug or drug combination would produce arousal most quickly without producing obvious undesirable side effects. Control group mean arousal time, mean walk time and mean duration of postarousal sedation were 66.1 minutes, 112.4 minutes and 5.6 hours, respectively. Naloxone (1.0 mg/kg) decreased mean arousal time to 10.8 minutes without significantly decreasing mean walk time or mean duration of postarousal sedation. The combination of naloxone + doxapram decreased mean arousal time and mean walk time to 1.0 minute and 57.1 minutes, respectively, without decreasing mean duration of postarousal sedation. In all groups, emergence from anesthesia was smooth. Relapses or undesirable side effects were not observed. Naloxone + doxapram is superior to naloxone alone for arousal of fentanyl-droperidol-pentobarbital-anesthetized dogs.
D015761:4-Aminopyridine; D000631:Aminopyridines / Q000494:pharmacology; D000758:Anesthesia / Q000662:veterinary*; D000777:Anesthetics / Q000008:administration & dosage*; D000818:Animals; D001143:Arousal / Q000187:drug effects*; D004285:Dogs / Q000601:surgery*; D004315:Doxapram / Q000008:administration & dosage / Q000494:pharmacology; D004329:Droperidol / Q000008:administration & dosage*; D004338:Drug Combinations / Q000008:administration & dosage; D005283:Fentanyl / Q000008:administration & dosage*; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology; D010424:Pentobarbital / Q000008:administration & dosage*; D015016:Yohimbine / Q000494:pharmacology
D000631:Aminopyridines; D000777:Anesthetics; D004338:Drug Combinations; D015016:Yohimbine; D009270:Naloxone; C001451:Innovar; D004315:Doxapram; D015761:4-Aminopyridine; D010424:Pentobarbital; D004329:Droperidol; D005283:Fentanyl